The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | J | Antiinfectives for systemic use | |
| 2 | J07 | Vaccines | |
| 3 | J07A | Bacterial vaccines |
| Code | Title | |
|---|---|---|
| J07AC | Anthrax vaccines | |
| J07AD | Brucellosis vaccines | |
| J07AE | Cholera vaccines | |
| J07AF | Diphtheria vaccines | |
| J07AG | Haemophilus influenzae B vaccines | |
| J07AH | Meningococcal vaccines | |
| J07AJ | Pertussis vaccines | |
| J07AK | Plague vaccines | |
| J07AL | Pneumococcal vaccines | |
| J07AM | Tetanus vaccines | |
| J07AN | Tuberculosis vaccines | |
| J07AP | Typhoid vaccines | |
| J07AR | Typhus (exanthematicus) vaccines | |
| J07AX | Other bacterial vaccines |
| Active Ingredient | Description | |
|---|---|---|
| Anthrax antigen |
Anthrax antigen induces antibodies raised against PA that may contribute to protection by neutralizing the activities of the cytotoxic lethal toxin and edema toxin of Bacillus anthracis. |
|
| Diphtheria toxoid |
|
|
| Haemophilus influenzae B |
Haemophilus influenza type B (Hib) is a bacteria responsible for severe pneumonia, meningitis and other invasive diseases almost exclusively in young children. Vaccines are the only public health tool capable of preventing the majority of serious Hib disease. |
|
| Haemophilus influenzae B, combinations with toxoids |
|
|
| Meningococcal group C conjugate vaccine |
|
|
| Meningococcal serogroup A polysaccharide vaccine |
|
|
| Meningococcal serogroup C polysaccharide vaccine |
|
|
| Meningococcal serogroup W135 polysaccharide vaccine |
|
|
| Meningococcal serogroup Y polysaccharide vaccine |
|
|
| Neisseria meningitidis OMPC |
|
|
| Pertactin |
|
|
| Pertussis toxoid |
|
|
| Pertussis, purified antigen |
|
|
| Pneumococcus, purified polysaccharides antigen |
|
|
| Saccharide meningococcal serogroup B |
|
|
| Tetanus toxoid |
|
|
| Typhoid, live attenuated |
Typhoid, live attenuated, vaccine contains strains of Salmonella typhi, the etiological agent of typhoid fever, an acute, febrile enteric disease. The S. typhi Ty21a vaccine strain, by virtue of a reduction in enzymes essential for lipopolysaccharide biosynthesis, is restricted in its ability to produce complete lipopolysaccharide. However, a sufficient quantity of complete lipopolysaccharide is synthesized to evoke a protective immune response. |
|
| Typhoid purified polysaccharide antigen |
|
| Title | Information Source | Document Type | |
|---|---|---|---|
| APEXXNAR Suspension for injection | European Medicines Agency (EU) | MPI, EU: SmPC | |
| BCG VACCINE Powder and solvent for suspension for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| BEXSERO Suspension for injection | European Medicines Agency (EU) | MPI, EU: SmPC | |
| BIOTHRAX Suspension for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| BOOSTRIX Suspension for injection in pre-filled syringe | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| DUKORAL Oral suspension / Granules | European Medicines Agency (EU) | MPI, EU: SmPC | |
| TYPHIM VI Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| VAXNEUVANCE Suspension for injection | European Medicines Agency (EU) | MPI, EU: SmPC | |
| VIVOTIF Typhoid vaccine capsule | FDA, National Drug Code (US) | MPI, US: SPL/Old |
